Anti-LTBP2/ C14orf141/ GLC3D functional antibody

Anti-LTBP2/ C14orf141/ GLC3D functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LTBP2/LTBP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0621-Ab-1/ GM-Tg-hg-SE0621-Ab-2Anti-Human LTBP2 monoclonal antibodyHuman
GM-Tg-rg-SE0621-Ab-1/ GM-Tg-rg-SE0621-Ab-2Anti-Rat LTBP2 monoclonal antibodyRat
GM-Tg-mg-SE0621-Ab-1/ GM-Tg-mg-SE0621-Ab-2Anti-Mouse LTBP2 monoclonal antibodyMouse
GM-Tg-cynog-SE0621-Ab-1/ GM-Tg-cynog-SE0621-Ab-2Anti-Cynomolgus/ Rhesus macaque LTBP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0621-Ab-1/ GM-Tg-felg-SE0621-Ab-2Anti-Feline LTBP2 monoclonal antibodyFeline
GM-Tg-cang-SE0621-Ab-1/ GM-Tg-cang-SE0621-Ab-2Anti-Canine LTBP2 monoclonal antibodyCanine
GM-Tg-bovg-SE0621-Ab-1/ GM-Tg-bovg-SE0621-Ab-2Anti-Bovine LTBP2 monoclonal antibodyBovine
GM-Tg-equg-SE0621-Ab-1/ GM-Tg-equg-SE0621-Ab-2Anti-Equine LTBP2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0621-Ab-1/ GM-Tg-hg-SE0621-Ab-2; GM-Tg-rg-SE0621-Ab-1/ GM-Tg-rg-SE0621-Ab-2;
GM-Tg-mg-SE0621-Ab-1/ GM-Tg-mg-SE0621-Ab-2; GM-Tg-cynog-SE0621-Ab-1/ GM-Tg-cynog-SE0621-Ab-2;
GM-Tg-felg-SE0621-Ab-1/ GM-Tg-felg-SE0621-Ab-2; GM-Tg-cang-SE0621-Ab-1/ GM-Tg-cang-SE0621-Ab-2;
GM-Tg-bovg-SE0621-Ab-1/ GM-Tg-bovg-SE0621-Ab-2; GM-Tg-equg-SE0621-Ab-1/ GM-Tg-equg-SE0621-Ab-2
Products NameAnti-LTBP2 monoclonal antibody
Formatmab
Target NameLTBP2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LTBP2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0621-Ag-1Recombinant multi-species LTBP2/ C14orf141/ GLC3D protein


    Target information

    Target IDGM-SE0621
    Target NameLTBP2
    Gene ID4053,16997,59106,699435,490784,101083010,281905,100056889
    Gene Symbol and SynonymsC14orf141,GLC3D,LTBP2,LTBP3,MSPKA,MSTP031,WMS3
    Uniprot AccessionQ14767,O35806,Q28019
    Uniprot Entry NameLTBP2_HUMAN,LTBP2_RAT,LTBP2_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseOvary Cancer, Mucocutaneous lymph node syndrome [Kawasaki]
    Gene EnsemblENSG00000119681
    Target ClassificationN/A

    The target: LTBP2, gene name: LTBP2, also named as C14orf141, GLC3D, LTBP3, MSPKA, MSTP031, WMS3. The protein encoded by this gene belongs to the family of latent transforming growth factor (TGF)-beta binding proteins (LTBP), which are extracellular matrix proteins with multi-domain structure. This protein is the largest member of the LTBP family possessing unique regions and with most similarity to the fibrillins. It has thus been suggested that it may have multiple functions: as a member of the TGF-beta latent complex, as a structural component of microfibrils, and a role in cell adhesion. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.